Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!
EMD-23471
SARS-CoV-2 spike complexed with Fab CV38-142 (3 Fabs bound)
EMD-23471
Single-particle27.8 Å
Deposition: 11/02/2021Map released: 05/05/2021
Last modified: 26/05/2021
Sample Organism:
Severe acute respiratory syndrome coronavirus 2,
Homo sapiens
Sample: SARS-CoV-2 spike complexed with Fab CV38-142 (3 Fabs bound)
Deposition Authors: Bangaru S, Ward AB
Sample: SARS-CoV-2 spike complexed with Fab CV38-142 (3 Fabs bound)
Deposition Authors: Bangaru S, Ward AB
A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection.
Liu H 
,
Yuan M ,
Huang D,
Bangaru S ,
Zhao F,
Lee CD,
Peng L ,
Barman S ,
Zhu X,
Nemazee D,
Burton DR,
van Gils MJ ,
Sanders RW,
Kornau HC,
Reincke SM ,
Pruss H,
Kreye J ,
Wu NC ,
Ward AB,
Wilson IA
(2021) Cell Host Microbe , 29 , 806 - 818.e6
,
Yuan M ,
Huang D,
Bangaru S ,
Zhao F,
Lee CD,
Peng L ,
Barman S ,
Zhu X,
Nemazee D,
Burton DR,
van Gils MJ ,
Sanders RW,
Kornau HC,
Reincke SM ,
Pruss H,
Kreye J ,
Wu NC ,
Ward AB,
Wilson IA
(2021) Cell Host Microbe , 29 , 806 - 818.e6
Grant Support:
- Bill & Melinda Gates Foundation: OPP1170236 (United States)
- National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID): P01 AI110657 (United States)